Study of an iron injection for people with iron deficiency anemia
Treatments studied
Part of Blood & lymphatic, Hormones & metabolism clinical trials.
This study tests an iron injection for treating iron deficiency anemia. It checks how the medicine works in the body, and may help people whose blood iron is too low.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You weigh at least 50 kg (about 110 pounds).
- You have anemia due to low iron, confirmed by blood tests.
- You are generally healthy, without major organ diseases.
- You agree to use effective birth control and avoid donating sperm or eggs during the study.
- You have not used certain iron treatments or donated blood recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a short course of intravenous (through a vein) iron called iron isomaltose can treat iron-deficiency anemia. It may help people who need faster iron replacement, but only if they meet key safety and health criteria.
This trial tests ferumoxytol, an intravenous iron medicine, to treat iron deficiency anemia in children who cannot take or did not respond well to iron by mouth. It aims to improve blood iron levels and anemia symptoms safely.
This study tests a new iron injection medication in healthy people to ensure it works the same way as a reference version. Participants will receive the injection while fasting and undergo blood tests to measure how the body processes the iron.
This study tests a new iron medicine (Ferric Bepectate) against an existing one (Ferric Carboxymaltose) to see if it works just as well for people with iron deficiency anemia. It aims to help patients with low iron and low hemoglobin get effective treatment.
This trial tests whether giving an intravenous iron supplement (ferric derisomaltose) can help prevent anemia and improve quality of life in obese patients who have low iron stores. It aims to see if this treatment can boost energy and reduce fatigue.
This trial studies IV ferric derisomaltose to treat iron deficiency anemia in children under 18. It is meant for children whose anemia is from a true iron problem and who either cannot tolerate or do not respond to iron taken by mouth, or have certain kidney-related causes.
Hear when a new Iron Deficiency Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.